a.mwangi
TL2 · Łódź
Contributes reviews on supplier material. Based in Łódź.
Joined 8 April 2025 · last posted 4d
73 posts, newest first. Showing up to 150.
-
Common supplements people ask about, assessed one at a time Replied, post #93 · Practice › Interactions · 24 Jul 2026 · 11 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #96 · Evidence › Journal club · 21 Jul 2026 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Priming a pen and whether the primed volume is wasted Replied, post #11 · Devices › Pens & autoinjectors · 18 Jul 2026 · 8 likes Storage instructions for a pen typically differ before and after first use, and the in-use period is the one people miss. It is on the carton.
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #21 · Analytics › Mass spectrometry · 17 Jul 2026 · 26 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #86 · Wellbeing › Sleep · 15 Jul 2026 · 0 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #40 · Evidence › Trials · 9 Jul 2026 · 0 likes What I would check first on Primary endpoint hierarchies is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a…
-
Immortal time bias in a claims-database study — one year on Replied, post #13 · Evidence › Study critique · 8 Jul 2026 · 12 likes I read post #9 twice before replying, because I had assumed the opposite. Trying to state the Immortal time bias position in a way that someone who disagrees would…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #109 · Outcomes › Body composition · 6 Jul 2026 · 13 likes Two things can be true about Lean mass preservation at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #37 · Practice › Dosing & titration · 4 Jul 2026 · 0 likes Understood. Thank you for being specific about the limits of it.
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #90 · Compounds › Semaglutide · 30 Jun 2026 · 3 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #3 · Analytics › HPLC & UHPLC · 29 Jun 2026 · 2 likes This is the answer, and the reason it is the answer is the more useful part.
-
Athletes in weight-category sports: a different risk calculus Replied, post #6 · Clinical › Special populations · 28 Jun 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #24 · Analytics › Home & field testing · 24 Jun 2026 · 12 likes Building on post #21 rather than restating it. Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #22 · Compounds › Semaglutide · 21 Jun 2026 · 3 likes Post #19 answers the question as asked. The question underneath it is different. Counter-ion form matters for the arithmetic and is almost never stated. A vial labelled…
-
What a certificate commits its issuer to — one year on Replied, post #90 · Analytics › COA interpretation · 17 Jun 2026 · 32 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
The headache that turns out to be dehydration — the long version Replied, post #46 · Nutrition & Training › Hydration & electrolytes · 5 Jun 2026 · 0 likes Careful with the language on headache. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #40 · Analytics › Method validation · 2 Jun 2026 · 0 likes Fair, and the limits you put on it are the part I will remember.
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #37 · Practice › Administration · 7 May 2026 · 2 likes Post #35 describes the usual case. This is about the unusual one. Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #8 · Evidence › Journal club · 24 Apr 2026 · 26 likes Everything in post #4 holds. The case it does not cover is the one I have. Since STEP 1 keeps coming up, it should probably be a maintained page rather than a recurring…
-
Batch numbers that do not match the vial label — what changed since Replied, post #2 · Sourcing › Red flags · 23 Apr 2026 · 31 likes Batch numbers is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Splitting an overlong document into two Replied, post #14 · Documentation › Wiki requests · 20 Apr 2026 · 6 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Five questions in one post gets you one answer — how to split them Replied, post #53 · Start Here › How to Ask · 12 Apr 2026 · 5 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #68 · Analytics › Mass spectrometry · 9 Apr 2026 · 0 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #66 · Practice › Administration · 7 Apr 2026 · 24 likes Injecting slowly is worth doing for volume rather than for chemistry. Larger volumes delivered quickly are the ones people report as uncomfortable. Two sources, same…
-
Why the timeline is on the right and not the left — what changed since Replied, post #15 · Meta › Site feedback · 4 Apr 2026 · 0 likes Adding a data point of agreement rather than a data point.
-
The "under review" status pill and when a moderator applies it Replied, post #31 · Evidence › Preprints · 21 Mar 2026 · 28 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Blinding yourself: practical methods and their limits Replied, post #12 · Research Methods › N-of-1 designs · 20 Mar 2026 · 2 likes Narrowing post #11, because the general version has more than one answer. An n of one tells you about one person, which is the person you are most interested in. That…
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #3 · marked as the solution · Practice › Reconstitution · 15 Mar 2026 · 7 likes The opening post describes the usual case. This is about the unusual one. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #2 · Evidence › Trials · 5 Mar 2026 · 29 likes I would keep Subgroup analyses and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #12 · Sourcing › Red flags · 3 Mar 2026 · 0 likes On supplier I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #3 · Analytics › Mass spectrometry · 11 Feb 2026 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. What mass accuracy establishes: the measured mass is consistent with a specific…
-
Amylin receptor signalling and satiety — what changed since Replied, post #21 · Pharmacology › Receptor biology · 26 Jan 2026 · 5 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #14 · Pharmacology › Pharmacokinetics · 12 Jan 2026 · 0 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #76 · Compounds › Tirzepatide · 11 Dec 2025 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Guidelines revision: what changed and why — one year on Replied, post #43 · Meta › Announcements · 5 Dec 2025 · 0 likes Adding the measurement that post #42 says would settle it. I disagree with the framing of Guidelines revision above, and I think it is a substantive disagreement rather…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #76 · Practice › Reconstitution · 26 Nov 2025 · 0 likes Answering the question post #72 raises rather than the one it answers. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps…
-
What a purity-only report leaves out Replied, post #102 · Sourcing › Independent verification · 25 Nov 2025 · 18 likes Adding the measurement that post #101 says would settle it. Repeat determination on the same product line months apart is the measurement that speaks to consistency,…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #7 · Safety › Contraindications · 18 Nov 2025 · 0 likes Severe gastroparesis is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
[2026 update] What steady state means for the decision to escalate Replied, post #43 · Practice › Dosing & titration · 9 Nov 2025 · 14 likes Everything in post #42 holds. The case it does not cover is the one I have. There is no published evidence about slower escalation because nobody studied it. That means…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #27 · Start Here › How to Ask · 26 Oct 2025 · 3 likes Reading back through, this was answered upthread and I missed it. My fault.
-
EMA product information as a primary source Replied, post #4 · Regional › European Union · 25 Oct 2025 · 0 likes Post #2 describes the usual case. This is about the unusual one. One more thing on EMA product information that took me far too long to see: the two figures people…
-
Which panel is worth repeating and which is worth ignoring Replied, post #132 · Clinical › Bloodwork · 8 Oct 2025 · 0 likes Add biological variation and analytical imprecision to that base rate and the probability of a meaningless flag on a multi-analyte panel is substantial. I would rather…
-
What a reversed-phase purity number actually is — the long version Replied, post #2 · Analytics › HPLC & UHPLC · 4 Oct 2025 · 13 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Hypertension improvement and when medication needs revisiting Replied, post #60 · Clinical › Comorbidities · 14 Sep 2025 · 31 likes Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote.
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #56 · Compounds › Semaglutide · 10 Sep 2025 · 1 like Picking up post #54: that is the part I would want checked first. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #18 · Devices › Pens & autoinjectors · 10 Sep 2025 · 17 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
-
A request that was declined, and the reasoning — a second dataset Replied, post #86 · Documentation › Wiki requests · 14 Aug 2025 · 14 likes The commonest reason a good request stalls is that nobody converted it into a draft. A rough draft attracts editors; a request does not.
-
What this community means by "a source", in practical terms Replied, post #67 · Start Here › Welcome · 11 Aug 2025 · 7 likes Adding a data point of agreement rather than a data point.
-
A supplier that answers analytical questions with restated claims Replied, post #119 · Sourcing › Red flags · 16 Jul 2025 · 9 likes Picking up post #118: that is the part I would want checked first. Having read the whole supplier thread before replying: the question in the first post has not…
-
Sodium, potassium and magnesium when intake drops Replied, post #32 · Nutrition & Training › Hydration & electrolytes · 26 Jun 2025 · 0 likes The failure mode on sodium is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
-
Vagal afferents and the gut-brain pathway Replied, post #6 · Pharmacology › Receptor biology · 2 Jun 2025 · 28 likes I read post #4 twice before replying, because I had assumed the opposite. Filing a mild objection to the consensus on vagal afferents. Mild because I might be wrong; an…
-
Pregnancy as an absolute contraindication Replied, post #76 · Safety › Contraindications · 19 May 2025 · 29 likes I had written a reply contradicting post #72 and deleted it. Here is what survived. A caution and a contraindication are different levels and the difference is not…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #2 · Practice › Reconstitution · 18 May 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. That…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #43 · Compounds › Cagrilintide & amylin analogues · 16 May 2025 · 0 likes Post #40 is the version of this I will quote in future. One addition. On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the…
-
Counter-ion content and its effect on measured mass Replied, post #31 · Analytics › Mass spectrometry · 4 May 2025 · 15 likes Post #29 and I disagree about the size of the effect, not about the direction. Resolution: "high resolution" commonly means
-
Requesting a translation of an existing page Replied, post #10 · Documentation › Wiki requests · 19 Apr 2025 · 9 likes This follows post #7 rather than contradicting it. Existing replies can be lifted into a draft with attribution, and their authors are generally pleased rather than…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #98 · Compounds › Cagrilintide & amylin analogues · 15 Apr 2025 · 4 likes Coming back to post #95, because the follow-up matters more than the original answer. Research-use-only cagrilintide is not approved for human use and the published…
-
Carryover and the ghost peak from last week's standard Replied, post #84 · Analytics › HPLC & UHPLC · 11 Apr 2025 · 7 likes Area percent is a proportion of absorbance, not a proportion of mass. Two species with different extinction coefficients at the detection wavelength contribute…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #50 · Compounds › Semaglutide · 24 Mar 2025 · 20 likes I had written a reply contradicting post #48 and deleted it. Here is what survived. Injection site does not appear to matter much for semaglutide exposure. The…
-
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #5 · Start Here › Welcome · 21 Mar 2025 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Maintainer handover: how it works Replied, post #74 · Meta › Wiki maintenance · 19 Mar 2025 · 0 likes Building on post #73 rather than restating it. Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #73 · Compounds › Cagrilintide & amylin analogues · 28 Feb 2025 · 1 like The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Validating a method you did not develop — does this still hold? Replied, post #34 · Analytics › Method validation · 22 Feb 2025 · 8 likes Post #30 describes the usual case. This is about the unusual one. The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #37 · Practice › Reconstitution · 20 Feb 2025 · 8 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Consistent declarations and why they matter more than clever ones Replied, post #46 · Sourcing › Logistics · 17 Feb 2025 · 0 likes My position on consistent declarations is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #48 · Devices › Cold chain · 7 Feb 2025 · 21 likes Following this. I have the same question and no better information than the first post.
-
Reading an MS report that only gives you a single number Replied, post #4 · Analytics › Mass spectrometry · 1 Feb 2025 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #35 · Compounds › Tirzepatide · 13 Nov 2024 · 6 likes Narrowing post #32, because the general version has more than one answer. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #87 · Compounds › Other compounds · 1 Nov 2024 · 8 likes On Melanocortin agonists, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Promotion criteria, and the one that stops most nominations Replied, post #84 · Documentation › Doc review · 12 Oct 2024 · 6 likes Check the links. Promotion frequently breaks a cross-reference because the source topic now points at the document rather than the reverse.
-
Guidelines revision: what changed and why Replied, post #28 · Meta › Announcements · 25 Jul 2024 · 0 likes Adding what did not work for me on guidelines revision, since the failures never get written up and they are half the useful information.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #38 · Compounds › Retatrutide · 18 Jul 2024 · 3 likes No notes. Posting so the count is not one.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #65 · Practice › Dosing & titration · 8 Jul 2024 · 0 likes This settles it for me, at least until somebody posts a reason it should not.